Cutia Therapeutics
HKEX:2487
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cutia Therapeutics
HKEX:2487
|
CN |
|
O
|
OM2 Network Co Ltd
TSE:7614
|
JP |
|
Mondi PLC
LSE:MNDI
|
UK |
|
Reinsurance Group of America Inc
NYSE:RGA
|
US |
|
IHI Corp
TSE:7013
|
JP |
|
TransDigm Group Inc
NYSE:TDG
|
US |
|
H
|
Hyundai Engineering & Construction Co Ltd
KRX:000720
|
KR |
|
G
|
Gorman-Rupp Co
NYSE:GRC
|
US |
|
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
IL |
|
Rexford Industrial Realty Inc
NYSE:REXR
|
US |
|
Smartfit Escola de Ginastica e Danca SA
BOVESPA:SMFT3
|
BR |
|
Moderna Inc
NASDAQ:MRNA
|
US |
|
Texas Pacific Land Corp
NYSE:TPL
|
US |
|
Avista Corp
NYSE:AVA
|
US |
|
Shopify Inc
NASDAQ:SHOP
|
CA |
|
Adapthealth Corp
NASDAQ:AHCO
|
US |
|
JD.Com Inc
HKEX:9618
|
CN |
Bankruptcy Probability
Cutia Therapeutics's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cutia Therapeutics Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Cutia Therapeutics
HKEX:2487
|
1.2B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
37.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cutia Therapeutics's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cutia Therapeutics has total debt of 135.2m CNY. This includes both short-term (0 CNY) and long-term (135.2m CNY) debt.
You can find a full breakdown on its Balance Sheet.
